Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Xilio Therapeutics, Inc.Listing on record | Buy | $208.5K | conv 25Cluster | SEC | |
Xilio Therapeutics, Inc.Listing on record | Buy | $32.6K | conv 24Cluster | SEC | |
Xilio Therapeutics, Inc.Listing on record | Buy | $39.5K | conv 33Cluster | SEC | |
Xilio Therapeutics, Inc.Listing on record | Buy | $129.5K | conv 49ClusterFirst in 12mo | SEC | |
Aptinyx Inc.Listing unverified | Buy | $10M | conv 62First in 12mo | SEC | |
Dicerna Pharmaceuticals IncListing unverified | Sell | $20M | SEC |